|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
US6132729A
(en)
|
1997-01-22 |
2000-10-17 |
Board Of Regents, The University Of Texas System |
Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment
|
|
US20050260177A1
(en)
*
|
1998-06-05 |
2005-11-24 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US7264801B2
(en)
*
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
|
US20020172678A1
(en)
*
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
|
CA2348781A1
(en)
*
|
1998-11-12 |
2000-05-25 |
Novolytics Inc. |
Compositions and methods for producing vascular occlusion
|
|
SI1187632T1
(sl)
*
|
1999-05-14 |
2009-04-30 |
Genentech Inc |
Zdravljenje z anti-ErbB2 protitelesi
|
|
US20030143233A1
(en)
*
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US7144991B2
(en)
|
1999-06-07 |
2006-12-05 |
Aletheon Pharmaceuticals, Inc. |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US20030103948A1
(en)
*
|
1999-06-07 |
2003-06-05 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
PT1198479E
(pt)
*
|
1999-07-01 |
2008-08-12 |
Univ Yale |
Imunoconjugados direccionados para alvos neovasculares
|
|
US6924359B1
(en)
|
1999-07-01 |
2005-08-02 |
Yale University |
Neovascular-targeted immunoconjugates
|
|
US6693176B1
(en)
*
|
1999-07-23 |
2004-02-17 |
University Of Massachusetts |
Antitumor antibodies, proteins, and uses thereof
|
|
JP2003508028A
(ja)
*
|
1999-07-28 |
2003-03-04 |
ジェネンテック・インコーポレーテッド |
腫瘍治療のための組成物と方法
|
|
US7217554B2
(en)
|
1999-08-31 |
2007-05-15 |
Novozymes A/S |
Proteases and variants thereof
|
|
EP2206786A1
(en)
*
|
1999-08-31 |
2010-07-14 |
Novozymes A/S |
Novel proteases and variants thereof
|
|
US6905683B2
(en)
|
2000-05-03 |
2005-06-14 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII variants
|
|
WO2001089566A1
(en)
|
2000-05-19 |
2001-11-29 |
Genentech, Inc. |
Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
|
|
TWI317285B
(en)
*
|
2000-07-28 |
2009-11-21 |
Dainippon Sumitomo Pharma Co |
New use and kit for remedies for cancer
|
|
RU2326126C2
(ru)
|
2000-09-13 |
2008-06-10 |
Ново Нордиск Хелт Кэр Аг |
Полипептид фактора vii свертывания крови, его получение и применение
|
|
WO2002038162A1
(en)
|
2000-11-09 |
2002-05-16 |
The Scripps Research Institute |
MODIFIED FACTOR VIIa
|
|
US7622437B2
(en)
*
|
2000-11-20 |
2009-11-24 |
The Board Of Trustees Of The University Of Illinois |
Tissue factor compositions and methods
|
|
US7132510B2
(en)
|
2000-12-29 |
2006-11-07 |
Bio-Technology General (Israel) Ltd. |
Specific human antibodies for selective cancer therapy
|
|
US20040001839A1
(en)
*
|
2000-12-29 |
2004-01-01 |
Avigdor Levanon |
Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
|
|
US20040001822A1
(en)
*
|
2000-12-29 |
2004-01-01 |
Avigdor Levanon |
Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
|
|
US20040002450A1
(en)
*
|
2000-12-29 |
2004-01-01 |
Janette Lazarovits |
Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
|
|
EP1353937A4
(en)
*
|
2000-12-29 |
2005-04-13 |
Savient Pharmaceuticals Inc |
SPECIFIC HUMAN ANTIBODIES FOR SELECTIVE CANCER THERAPY
|
|
TWI233359B
(en)
*
|
2001-04-06 |
2005-06-01 |
Wyeth Corp |
Pharmaceutical composition for treating neoplasm
|
|
TWI296196B
(en)
*
|
2001-04-06 |
2008-05-01 |
Wyeth Corp |
Antineoplastic combinations
|
|
US7419949B2
(en)
*
|
2001-07-16 |
2008-09-02 |
Novo Noridsk Healthcare A/G |
Single-dose administration of factor VIIa
|
|
US7052868B2
(en)
|
2001-09-27 |
2006-05-30 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
|
US20030129193A1
(en)
*
|
2001-09-27 |
2003-07-10 |
Board Of Regents, The University Of Texas System And Peregrine Pharmaceuticals, Inc. |
Combined methods for tumor vasculature coaguligand treatment
|
|
US7205275B2
(en)
|
2001-10-11 |
2007-04-17 |
Amgen Inc. |
Methods of treatment using specific binding agents of human angiopoietin-2
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
US7399743B2
(en)
*
|
2001-10-26 |
2008-07-15 |
The Scripps Research Institute |
Targeted thrombosis
|
|
US6960657B2
(en)
|
2001-11-02 |
2005-11-01 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
|
WO2003054146A2
(en)
*
|
2001-11-14 |
2003-07-03 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
|
EP1467752A4
(en)
*
|
2002-01-03 |
2005-12-07 |
Tanox Inc |
HUMAN MAST CELL EXPRESSED MEMBRANE PROTEINS
|
|
AU2003215280A1
(en)
*
|
2002-02-15 |
2003-09-09 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
|
US20040102402A1
(en)
*
|
2002-11-22 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of tissue factor expression
|
|
WO2005014775A2
(en)
*
|
2002-06-28 |
2005-02-17 |
University Of Florida Research Foundation, Inc. |
Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a
|
|
US20040202665A1
(en)
*
|
2002-07-01 |
2004-10-14 |
Janette Lazarovits |
Compositions and methods for therapeutic treatment
|
|
US20040208877A1
(en)
*
|
2002-07-01 |
2004-10-21 |
Avigdor Levanon |
Antibodies and uses thereof
|
|
DE60335383D1
(de)
|
2002-07-15 |
2011-01-27 |
Univ Texas |
Antikörper mit bindung an anionische phospholipide und aminophospholipide und ihre verwendung bei der behandlung von virusinfektionen
|
|
WO2004018628A2
(en)
|
2002-08-21 |
2004-03-04 |
Northwestern University |
Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom
|
|
US6911323B2
(en)
|
2002-09-25 |
2005-06-28 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
|
US7683025B2
(en)
*
|
2002-11-14 |
2010-03-23 |
Northwestern University |
Synthesis and self-assembly of ABC triblock bola peptide amphiphiles
|
|
US20040115204A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Fanger Gary R. |
Antibodies to treat cancer
|
|
WO2004072104A2
(en)
|
2003-02-11 |
2004-08-26 |
Northwestern University |
Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
|
|
EP2085470B1
(en)
*
|
2003-03-20 |
2012-05-16 |
Bayer HealthCare LLC |
FVII or FVIIa variants
|
|
SI1624891T2
(sl)
|
2003-05-06 |
2013-09-30 |
Biogen Idec Hemophilia Inc. |
Strjevalni faktor-FC himerni proteini za zdravljenje hemofilije
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
US20110002978A1
(en)
|
2003-06-17 |
2011-01-06 |
Harrison Roger G |
Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof
|
|
US20070207158A1
(en)
*
|
2003-06-17 |
2007-09-06 |
Harrison Roger G |
Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
|
|
US20050152906A1
(en)
*
|
2003-06-30 |
2005-07-14 |
Avigdor Levanon |
Specific human antibodies
|
|
US20050069955A1
(en)
*
|
2003-06-30 |
2005-03-31 |
Daniel Plaksin |
Antibodies and uses thereof
|
|
CA2534996A1
(en)
*
|
2003-08-06 |
2005-05-06 |
Hans Prydz |
The use of sirna silencing in the prevention of metastasis
|
|
DE10338733A1
(de)
*
|
2003-08-22 |
2005-03-24 |
Berdel, Wolfgang E., Prof. Dr.med. |
Fusionspolypeptide und deren Verwendung für die antivaskuläre Tumortherapie
|
|
CN101870729A
(zh)
|
2003-09-09 |
2010-10-27 |
诺和诺德医疗保健公司 |
凝固因子ⅶ多肽
|
|
KR20070004560A
(ko)
*
|
2003-12-05 |
2007-01-09 |
노오쓰웨스턴 유니버시티 |
성장 인자 전달을 위한 자가조립 펩티드 친양매성 화합물들및 관련 방법들
|
|
WO2005056576A2
(en)
|
2003-12-05 |
2005-06-23 |
Northwestern University |
Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
|
|
MX361174B
(es)
|
2003-12-23 |
2018-11-29 |
Genentech Inc |
Anticuerpos anti-il13 novedosos y sus usos.
|
|
WO2005077333A2
(en)
*
|
2004-02-10 |
2005-08-25 |
University Of Florida Research Foundation, Inc. |
Gel-based delivery of recombinant adeno-associated virus vectors
|
|
EP1732594A4
(en)
*
|
2004-03-18 |
2007-10-17 |
St Lukes Hospital |
METHOD FOR THE ADMINISTRATION OF AGENTS WITH DELAYED RELEASE
|
|
EP1761231A1
(en)
*
|
2004-06-07 |
2007-03-14 |
Duramed Pharmaceuticals, Inc. |
Dispenser for progestin used for acute and maintenance treatment of dub
|
|
CA2580796C
(en)
*
|
2004-09-24 |
2013-03-26 |
Amgen Inc. |
Modified fc molecules having peptides inserted in internal loop regions
|
|
WO2006047684A2
(en)
*
|
2004-10-27 |
2006-05-04 |
The Board Of Trustees Of The University Of Illinois, Et Al. |
Tissue factor phospholipid vesicle particles and methods of use for coagulation
|
|
KR20070108555A
(ko)
*
|
2005-03-04 |
2007-11-12 |
노오쓰웨스턴 유니버시티 |
혈관신생 헤파린 결합 펩티드 양친매성 화합물
|
|
US7393833B2
(en)
*
|
2005-03-09 |
2008-07-01 |
The Board Of Regents Of The University Of Oklahoma |
Chimeric proteins with phosphatidylserine binding domains
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
US8076295B2
(en)
*
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
|
GB0723712D0
(en)
*
|
2007-12-04 |
2008-01-16 |
Apitope Technology Bristol Ltd |
Peptides
|
|
BRPI0908737B1
(pt)
|
2008-03-19 |
2022-05-03 |
Circular Commitment Company |
Anticorpo, seu uso e método de diagnóstico de carcinoma hepatocelular
|
|
NZ594698A
(en)
|
2009-02-05 |
2013-08-30 |
Pierre Philippart |
Method and means for producing tissues and tissues obtained
|
|
EP2419116A1
(en)
*
|
2009-04-13 |
2012-02-22 |
North Western University |
Novel peptide-based scaffolds for cartilage regeneration and methods for their use
|
|
CN102153653B
(zh)
*
|
2010-12-30 |
2012-08-15 |
厦门大学 |
肿瘤血管靶向多肽与组织因子的融合蛋白及其制备方法
|
|
PL3044323T3
(pl)
|
2013-09-13 |
2022-06-27 |
F.Hoffmann-La Roche Ag |
Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych
|
|
SG11201601823TA
(en)
|
2013-09-13 |
2016-04-28 |
Genentech Inc |
Methods and compositions comprising purified recombinant polypeptides
|
|
US9493552B2
(en)
|
2013-11-15 |
2016-11-15 |
China Synthetic Rubber Corporation |
Therapeutic biologic for treatment of hepatocellular carcinoma
|
|
US9987241B2
(en)
|
2014-09-25 |
2018-06-05 |
The Board Of Regents Of The University Of Oklahoma |
Enzyme conjugate and prodrug cancer therapy
|
|
CN104387474B
(zh)
*
|
2014-11-17 |
2018-01-23 |
北京华安科创生物技术有限公司 |
一种肿瘤血管梗塞剂多肽、基因、表达载体及其应用
|
|
CN106699875A
(zh)
*
|
2017-02-23 |
2017-05-24 |
青岛古高生物科技有限公司 |
一种人重组组织因子及其基因、表达载体、宿主菌和表达方法
|
|
WO2020032951A1
(en)
|
2018-08-09 |
2020-02-13 |
The Board Of Regents Of The University Of Oklahoma |
Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same
|
|
CN108948209A
(zh)
*
|
2018-07-17 |
2018-12-07 |
广西医科大学 |
一种cd105单链抗体-es融合蛋白的制备方法和用途
|
|
CN109999182B
(zh)
*
|
2019-03-29 |
2023-03-07 |
四川大学华西医院 |
凝血因子在制备抗肿瘤药物中的应用
|
|
CN122094976A
(zh)
*
|
2023-10-31 |
2026-05-26 |
免疫生物公司 |
多链嵌合多肽和其用途
|